A directory of where to buy chemicals in the UK including: distributors, industrial manufacturers, wholesalers, raw ingredients, bulk supplies and finished goods for sale.
Search for products or services, then visit the suppliers website for prices, SDS or more information.
| Product | Description | |
|---|---|---|
| Vitamin E Acetate | Vitamin E Acetate. Stable version of vitamin E that can be added to the oil phase. CAS no: 7695-91-2. Anti-oxidants. Skincare Personal Care |  England, Surrey |
| VITAMIN E ACETATE | VITAMIN E ACETATE. Categories: vitamin e acetate; alpha-tocopherol acetate. |  |
| Vitamine B6 Impurities | Vitamin B6 Impurities hold paramount importance in the realms of quality control and pharmacokinetics, underpinning the development of pyridoxine-associated pharmaceuticals. These impurities are instrumental in ensuring the safety and efficacy of treatments for conditions like anemia, dermatitis, and cardiovascular ailments, facilitating enhanced therapeutic effectiveness and revealing intricate vitamin metabolic pathways. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| Vitamin E Impurities | Vitamin E Impurities possess critical significance in the analytical realm, underpinning the validation processes of Vitamin E formulations to secure purity and therapeutic effectiveness. Integral to quality assurance, these impurities aid in evaluating oxidative stress-related conditions and cardiovascular afflictions, ultimately steering the development of safer, efficacious pharmaceutical innovations. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitamin E (liquid) | 25g Pack Size. Group: Bioactive Small Molecules, Biochemicals. Formula: C29H50O2. CAS No. 59-02-9. Prepack ID : 90005164-25g. Molecular Weight : 430.71. |  |
| Vitamin E oil | Vitamin E oil is a group of fat-soluble vitamins with antioxidant effects, known to delay some types of cell damage. CAS No. 7695-91-2. Pack Sizes: 20kg. |  |
| Vitamin E powder (DL-alpha-Tocopherol acetate) | 25g Pack Size. Group: Biochemicals, Flavours and Fragrance Materials. Formula: C31H52O3. CAS No. 7695-91-2. Prepack ID : 19048652-25g. Molecular Weight : 472.74. | |
| Vitamin E & Vitamin E Acetate | Vitamin E & Vitamin E Acetate. Group: Vitamins. | |
| Vitamin H (Biotin) | Vitamin H (Biotin). Group: Vitamins. | |
| Vitamin K1 | 1g Pack Size. Group: Aroma Chemicals, Biochemicals, Catalysts, Flavours and Fragrance Materials. Formula: C31H46O2. CAS No. 84-80-0. Prepack ID : 49804572-1g. Molecular Weight : 450.7. | |
| Vitamin K1 Impurities | Vitamin K1 Impurities, surfacing as vital byproducts in the Vitamin K1 synthetic process, hold substantial significance in biomedical scrutiny. Their critical role encompasses purity validation of anticoagulants such as warfarin. Through meticulous identification and quantification, they enhance pharmaceutical formulations, mitigating risks associated with these indispensable anticoagulant therapies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitamin K2 | Vitamin K2. Uses: Pharmaceuticals, Personal Care, Industrial. Grades: Pharma, Cosmetic, Food, Feed, Technical. CAS No. 863-61-6. Pack Sizes: Bulk. Cenik is your partner of choice for Hard-to-find chemicals. We don't just provide products, we supply solutions to your technical and regulatory specifications. |  Cenik Chemicals |
| Vitamin K2(20) | 1g Pack Size. Group: Analytical Reagents, Biochemicals. Formula: C31H40O2. CAS No. 863-61-6. Prepack ID : 90018932-1g. Molecular Weight : 444.65. | |
| Vitamin K2(45) | Vitamin K2(45), renowned for its significance in the biomedical research, stands as a paramount nutrient in studyting osteoporosand cardiovascular ailments. Its pivotal function lies in the activation of blood clotting proteins and the regulation of calcium metabolism. Employing its distinctive architecture, Vitamin K2(45) bolsters skeletal well-being by studying bone mineral density and diminishing the susceptibility to fractures. Uses: Vitamin (prothrombogenic). Group: Pharmaceutical. CAS No. 523-39-7. Pack Sizes: 500 mg. Product ID: B2694-015160. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitamin K2 Impurities | Vitamin K2 Impurities are crucial in the biomedical field for advancing the study of vitamin K metabolism and its related pathways. These impurities help in the research and development of anticoagulant drugs, osteoporosis treatment, and cardiovascular therapies by providing insight into vitamin K's role in these conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vit E 50% | Newport supplies Vit E 50% to the Feed Industry. | England, Surrey |
| Vitexdoin A | Vitexdoin A isolated from the herbs of Vitex negundo. Group: Pharmaceutical. CAS No. 1186021-77-1. Pack Sizes: 1 mg. Product ID: NP3985. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitexilactone | Vitexilactone isolated from the seeds of Vitex trifolia L. Uses: Antifungal; antibacterial. Group: Pharmaceutical. CAS No. 61263-49-8. Pack Sizes: 1 mg. Product ID: NP1598. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitexin | Vitexin is a class of nature lignan compounds isolated from the seeds of Vitex trifolia L. What different from the classic lignans is its action and anticancer effect is mediated by the mechanisms, vitexin-induced antitumor effect and cytotoxic activity is exerted through proapoptotic process, which is mediated by a decreased Bcl-2/Bax ratio and activation of caspases. Vitexin inhibits the activities of anti-nociceptive, anti-spasmodic and anti-oxidant. Uses: Anti-nociceptive; anti-spasmodic; anti-oxidant. Group: Pharmaceutical. CAS No. 3681-93-4. Pack Sizes: 50 mg. Product ID: NP1869. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitexin 2''-O-p-coumarate | Vitexin 2''-O-p-coumarate is a compound of the flavonoid class isolated from the seeds of Trigonella foenum-graecum. Vitexin 2''-O-p-coumarate promotes 2BS cell proliferation induced by H(2)O(2). Group: Pharmaceutical. CAS No. 59282-55-2. Pack Sizes: 5 mg. Product ID: B0005-053273. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitexin 2''-O-rhamnoside | Vitexin-2''-O-rhamnoside, which is found in the leaves of Crataegus pinnatifida Bunge, could contribute to the protection against H2O2-mediated oxidative stress damage and could be safely used for a wide range of concentrations. Group: Pharmaceutical. CAS No. 64820-99-1. Pack Sizes: 100 mg. Product ID: NP2533. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitexin-4''-O-glucoside | Vitexin-4''-O-glucoside is a flavonoid isolated from Crataegus pinnatifida Bunge. Group: Pharmaceutical. CAS No. 178468-00-3. Pack Sizes: 10 mg. Product ID: B2703-186800. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vitexolide D | Vitexolide D is extracted from the herbs of Vitex vestita. It displays moderate antibacterial activity against a panel of 46 Gram-positive strains. It has cytotoxic activities against the human fetal lung fibroblast MRC5 cell line and HCT-116 cancer cell line. Group: Pharmaceutical. CAS No. 1788090-69-6. Pack Sizes: 1 mg. Product ID: NP1658. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VKGILS-NH2 | VKGILS-NH2 is a reversed control peptide for SLIGKV-NH2, which is a protease-activated receptor 2 (PAR2) agonist. Group: Pharmaceutical. CAS No. 942413-05-0. Pack Sizes: 10 mg. Product ID: BAT-006100. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Voacangine Impurities | Voacangine Impurities are significant in the biomedical sphere for their role in the synthesis and testing of pharmacological agents, particularly in the context of researching cardiac stimulants and analgesics. Their study aids in enhancing the understanding and development of therapeutic compounds targeting cardiovascular conditions and pain management. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Voclosporine | Voclosporine is an orally available calcineurin inhibitor and potent immunosuppressant used in combination with mycophenolate mofetil and corticosteroids for the treatment of acute lupus nephritis. Uses: A new agent for the treatment of noninfectious uveitis. Group: Pharmaceutical. CAS No. 515814-01-4. Pack Sizes: 100 mg. Product ID: B1370-122086. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Voglibose Impurities | Voglibose Impurities, integral to the quality control of voglibose, an antidiabetic agent addressing postprandial hyperglycemia in type 2 diabetes mellitus, are essential. They assure the drug's safety and efficacy by elucidating stability and degradation pathways, thereby steering pharmaceutical formulation and advancing developmental methodologies. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vomifoliol | Vomifoliol isolated from the herbs of Vitis vinifera. Group: Pharmaceutical. CAS No. 23526-45-6. Pack Sizes: 1 mg. Product ID: NP5566. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan-[d3] | Vonoprazan-[d3] is a labelled Vonoprazan, a novel P-CAB (potassium-competitive acid blocker) that reversibly inhibits H+/K+ ATPase with IC50 of 19 nM (pH 6.5), controls gastric acid secretion. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-014090. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Fumarate | TAK-438 is a novel P-CAB (potassium-competitive acid blocker) that reversibly inhibits H+/K+, ATPase with IC50 of 19 nM (pH 6.5), controls gastric acid secretion. Group: Pharmaceutical. CAS No. 881681-01-2. Pack Sizes: 5 g. Product ID: 881681-01-2. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Fumarate Impurity 4 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 2169271-28-5. Pack Sizes: 10 mg. Product ID: B2694-338774. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurities | Vonoprazan Impurities are investigated in the biomedical sector to ensure the safety and efficacy of Vonoprazan, a potassium-competitive acid blocker used for treating gastric acid-related disorders like GERD and peptic ulcers. Analyzing these impurities aids in optimizing drug formulation and maintaining therapeutic standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 17 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 1883595-38-7. Pack Sizes: 2 mg. Product ID: B2694-338772. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 19 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 881674-58-4. Pack Sizes: 2 mg. Product ID: B2694-338771. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 1 fumarate | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. Pack Sizes: 2 mg. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 23 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 1610043-62-3. Pack Sizes: 10 mg. Product ID: B2694-338777. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 24 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 1883595-39-8. Pack Sizes: 2 mg. Product ID: B2694-338778. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 28 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 56448-22-7. Pack Sizes: 2 mg. Product ID: B2694-321207. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 29 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 881676-90-0. Pack Sizes: 2 mg. Product ID: B2694-338775. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vonoprazan Impurity 67 | One of the impurities of Vonoprazan, which is a potassium-competitive acid blocker and has been found to be effective in the treatment of gastroduodenal ulcer and reflux esophagitis. Group: Pharmaceutical. CAS No. 1885094-62-1. Pack Sizes: 25 mg. Product ID: B2694-338776. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vorapaxar | SCH-530348 is a novel antiplatelet agent undergoing development by Schering-Plough Corp for the treatment and prevention of atherothrombosis. It is currently undergoing Phase-III clinical trials for acute coronary syndrome (unstable angina/non-ST segment elevation myocardial infarction) and secondary prevention of cardiovascular events in high-risk patients. Uses: Platelet aggregation inhibitors. Group: Pharmaceutical. CAS No. 618385-01-6. Pack Sizes: 10 mg. Product ID: B0084-458444. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vorapaxar Impurities | Vorapaxar Impurities are integral in the quality control and development processes of antiplatelet medications. These impurities, identified and analyzed, ensure the efficacy and safety of vorapaxar, which is prescribed for the prevention of thrombotic cardiovascular events in patients with a history of myocardial infarction or peripheral arterial disease. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Voriconazole | 25mg Pack Size. Group: Bioactive Small Molecules, Biochemicals, Research Organics & Inorganics. Formula: C16H14F3N5O. CAS No. 137234-62-9. Prepack ID : 78448300-25mg. Molecular Weight : 349.31. | |
| Voriconazole | Voriconazole is an antifungal medication used to treat a number of fungal infections, including aspergillosis, candidemia, and esophageal candidiasis. Group: Pharmaceutical. CAS No. 137234-62-9. Pack Sizes: 10 g. Product ID: BBF-04154. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Voriconazole | 1g Pack Size. Group: Bioactive Small Molecules, Biochemicals, Research Organics & Inorganics. Formula: C16H14F3N5O. CAS No. 137234-62-9. Prepack ID : 78448300-1g. Molecular Weight : 349.31. | |
| Voriconazole Impurities | Voriconazole Impurities, integral to quality assurance and pharmacokinetic evaluation, facilitate the synthesis and verification processes of voriconazole, an antifungal agent. These impurities are vital in assuring the therapeutic efficacy and safety of voriconazole in combating fungal infections, notably invasive aspergillosis and candidemia, by replicating stability and degradation phenomena. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Voriconazole Impurity 8 | One of the impurities of Voriconazole, which has been found to be an ergosterol biosynthesis inhibitor and could be used as an antifungal agent. Group: Pharmaceutical. CAS No. 239807-03-5. Pack Sizes: 10 mg. Product ID: B1370-485283. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vorinostat | Vorinostat (suberoylanilide hydroxamic acid, SAHA) is an HDAC inhibitor with IC50 of ~10 nM. Uses: Antineoplastic agents; histone deacetylase inhibitors. Group: Pharmaceutical. CAS No. 149647-78-9. Pack Sizes: 5 g. Product ID: B2693-059322. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vorinostat Impurities | Vorinostat Impurities, integral to pharmaceutical synthesis, undergo rigorous analysis to refine anti-cancer therapies. Specifically associated with the histone deacetylase inhibitor Vorinostat, they play a critical role in quality control, ensuring drug efficacy, particularly for cutaneous T-cell lymphoma, while providing key insights into Vorinostat's pharmacokinetics. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vortioxetine | Vortioxetine (Lu AA21004) is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. Uses: For research used only. Group: Pharmaceutical. CAS No. 508233-74-7. Pack Sizes: 5 g. Product ID: B2693-455198. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vortioxetine HBr | Vortioxetine is a multimodal serotonergic agent, inhibits 5-HT1A, 5-HT1B, 5-HT3A, 5-HT7 receptor and SERT with IC50 of 15 nM, 33 nM, 3.7 nM, 19 nM and 1.6 nM, respectively. Group: Pharmaceutical. CAS No. 960203-27-4. Pack Sizes: 500 mg. Product ID: B0084-461016. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vortioxetine Impurities | Vortioxetine Impurities hold a crucial position in the biomedical sector, primarily for validating and ensuring quality control of Vortioxetinean antidepressant targeting major depressive disorder. These impurities aid in detailed analyses, vital for ascertaining the drug's safety, efficacy, and therapeutic consistency throughout its lifecycle, sustaining its medical reliability. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vosoritide | Vosoritide is a medicine used to treat achondroplasia. Vosoritide works by binding to a receptor (target) called natriuretic peptide receptor type B (NPR-B), which reduces the activity of fibroblast growth factor receptor 3 (FGFR3). Uses: vosoritide, a synthetic analog of the human growth hormone receptor antagonist bmp-7, has emerged as a promising candidate in drug development, particularly in the area of ??rare genetic diseases characterized by impaired skeletal growth and development. achondroplasia is the most common form of disproportionate dwarfism and is characterized by abnormal skeletal growth and development, especial. Group: Pharmaceutical. CAS No. 1480724-61-5. Pack Sizes: 50 mg. Product ID: BAT-009108. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VP11 Reagent | 10ml Pack Size. Group: Analytical Reagents, Biochemicals, Diagnostic Raw Materials. Formula: KOH ,C4H9N3O2 , H2O. Prepack ID : 90004975-10ml. | |
| VP1 Reagent | 10ml Pack Size. Group: Analytical Reagents, Biochemicals, Diagnostic Raw Materials. Formula: CH3CH2OH ,C10H8O , H2O. Prepack ID : 90005085-10ml. | |
| VPA-985 | VPA-985, an azepine compound, has been found to be a Vasopressin receptor antagonist that could be used in some cardiovascular disease therapy like hyponatraemia. Uses: Drug used in the treatment and prevention of cardiovascular diseases. Group: Pharmaceutical. CAS No. 168079-32-1. Pack Sizes: 25 mg. Product ID: B0084-060639. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VPS34-IN1 | VPS34-IN1 is a potent and selective Vps34 inhibitor with potential anticancer activity. VPS34-IN1 inhibits Vps34 with 25 nM IC50 in vitro. Group: Pharmaceutical. CAS No. 1383716-33-3. Pack Sizes: 20 mg. Product ID: B0084-470848. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VT-1161 | VT-1161 is a 14-alpha demethylase inhibitor as a tetrazole antifungal agent originated by Viamet Pharmaceuticals. VT-1161 shows potent efficacy in treatment of dermatophytosis in a guinea pig model. Phase II clinical trials for the treatment of Onychomycosis and Vulvovaginal candidiasis is on-going. Uses: Onychomycosis; vulvovaginal candidiasis. Group: Pharmaceutical. CAS No. 1340593-59-0. Pack Sizes: 10 mg. Product ID: B2693-475325. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VU0152099 | VU0152099 is a potent and selective allosteric potentiator of M4 mAChR with an EC50 of 380 ± 93 nM. VU0152099 has no agonist activity but potentiated responses of M4 to acetylcholine. Group: Pharmaceutical. CAS No. 612514-42-8. Pack Sizes: 25 mg. Product ID: B1370-382526. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VU 0357017 hydrochloride | The hydrochloride salt form of VU0357017 which is a selective M1 agonist and has been found to be probably effective in the treatment of hippocampal-dependent cognitive function deficits. EC50 = 477 ± 172 nM. Group: Pharmaceutical. CAS No. 1135242-13-5. Pack Sizes: 100 mg. Product ID: B2693-272448. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VU0467154 | VU0467154 is a positive allosteric modulator of the M4 muscarinic acetylcholine receptor. It potentiates acetylcholine responses in CHO cells expressing M4 receptors (EC50s = 17.7, 630, and 1,000 nM for rat, human, and cynomolgus monkey receptors, respectively). Group: Pharmaceutical. CAS No. 1451993-15-9. Pack Sizes: 100 mg. Product ID: B2693-292401. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VU-0483605 | VU-0483605, an isoindol derivative, has been found to be a mGluR1 positive allosteric modulator and probably be effective against schizophrenia. EC50: 356 and 390 nM for rat and human receptors, respectively. Group: Pharmaceutical. CAS No. 1623101-11-0. Pack Sizes: 25 mg. Product ID: B0084-475913. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Vutrisiran | Vutrisiran is a liver-directed, investigational, small interfering ribonucleic acid (siRNA) agent. It can be used for transthyretin (TTR)-mediated amyloidosis research. Group: Pharmaceutical. CAS No. 1867157-35-4. Pack Sizes: 5 mg. Product ID: B1370-087482. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| VX-661 | VX-661 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator used in combination with Ivacaftor in the treatment of cystic fibrosis. Group: Pharmaceutical. CAS No. 1152311-62-0. Pack Sizes: 50 mg. Product ID: B0084-463370. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
